Delivery Order SPE2DB20D3101-SPE2DB22FJ0D9
- Not listed
- This federal contract award is for the delivery of Shingrix vial kits to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $6,813.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 19, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,554.45. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm fixed-price contract has a ceiling value of $34,267.50 and a completion date of December 4, 2024. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,531.94, is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $14,088.78, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of January 23, 2023. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of SHINGRIX vaccine kits to the Defense Logistics Agency (DLA), a defense agency. The $4,750.75 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This single-award...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 4, 2024, with a ceiling value of $3,651.18 and a completion date of June 5, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $10,099.02, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,291.21 and was awarded on August 12, 2021 with an ultimate completion date of August 13, 2021. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside...
- This federal contract award is for the delivery of SHINGRIX vial kits, a vaccine product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $10,690.10 with a completion date of January 26, 2023. This is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ0D9Delivery Order
This federal contract award is for the delivery of Shingrix vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.42, is a Firm Fixed Price Delivery Order with an ultimate completion date of March 8, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/7/22 |